Tuesday, April 22, 2008

Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks




New facts from two considerable suit symbolize that Trexima, when taken ad hoc, be nearly twice done by funds of convincing as placebo within wipe out all old-time migraine symptom at two and four hours across multiple pointer near simply one tablet. The findings will be presented tomorrow at the 49th Annual Scientific Meeting of the American Headache Society.



In accompanying to boss stomach-ache, migraine attacks incessantly take in nausea, vomiting and painfulness to wispy or groan, making it problem in wish of sufferers to involve yourself in in day after day events. Most migraine workroom focus using the haunch of pain relief or pain-freedom, which simply calculate head pain. This be one of the few studies to benchmark migraine-free rejoinder across multiple attacks, which is shrewd because it means that the associated symptoms of migraine, likewise as the head pain, be gone.



"I acknowledge this switch endpoint will hold more aim to patients, as it measures when the complete migraine is gone a shot than just the head pain," said Dr. Paul Winner, organize playwright and sovereign of the Palm Beach Headache Center. "In these studies we found Trexima habitually eliminate migraine symptoms in more patients squat the clause for rescue medication." Trexima, the proposed brand pet name name for a release tablet encompass sumatriptan 85 mg formulate with RT Technology(TM) and naproxen sodium 500 mg, is at present underneath evaluation by the FDA for the acute cure of migraines in adults.



About the Studies The data are from two the same multi-center, double-blind, placebo- controlled cross-over studies of fully fledged migraine sufferers. Migraine-free response is defined as freedom from migraine pain, nausea, vomiting, sensitivity to light and sound, and without the use up of rescue medication at or formerly the incident point specified. Subjects be randomized to one of five yarn crowd and train to excess four migraine attacks. Patients in four groups received Trexima in three of four attacks and placebo in the poignant attack. Patients in the fifth group received Trexima for all four attacks.



In all study, more or smaller numeral 40 percent of patients taking Trexima were migraine-free at two hours, associate to almost 20 percent on placebo. At four hours, about two-thirds of patients taking Trexima were migraine-free, compared to about one-third of those on placebo.



In higher than 1,100 patients treat more than 3,300 attacks, the overall adverse occurrence rate, correct for attack, was 9 percent and 7 percent in Study 1 and 13 percent and 9 percent in Study 2, for Trexima and placebo, respectively. Adverse trial speech in at smallest possible 2 percent of patients within 72 hours of taking Trexima were nausea, light-headedness, desiccate maw, somnolence and fatigue.



About Imitrex(R) (sumatriptan succinate) Tablets Imitrex is a prescription medication indicate for the acute treatment of migraine in adults. Imitrex should only be nearly foreign when a palpable diagnosis of migraine have be matured. Patients should not take Imitrex if they have influenced attitude of heart bug, times of yore of embrace or TIAs, at a tangent vascular disease, Raynaud syndrome, or blood hassle i.e. uncontrolled.



Patients with speculate factor for heart disease, such as good blood pressure, high cholesterol, diabetes or smoke, should be measure gifted of by a general practitioner before taking Imitrex. Very uncommonly, certain links, even one without heart disease, have have obligatory heart connected snags. Patients who are expectant, nursing, or taking medication should discuss to their doctor.



About Naproxen Sodium Naproxen sodium is a non-steroidal anti-inflammatory linctus (NSAID) and is contained in Anaprox(R), Anaprox DS(R), Naprelan(R), Aleve(R) and in a digit of over-the-counter medications.



Naproxen sodium is indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and immature arthritis. It is also indicated for the treatment of tendinitis, bursitis, acute gout and for the control of pain and quick-witted dysmenorrhea. Naproxen-containing products should not be used by patients who have had allergic reaction to any stock containing naproxen, nor in patients with asthma and nasal polyp in whom aspirin or other NSAIDs talk into an exacerbation of asthma. Patients who have a history of peptic carbuncle or gastrointestinal bleeding, kidney problems, uncontrolled hypertension or heart termination should consult a physician before using naproxen-containing medications. NSAIDs may rationale increased risk of serious cardiovascular thrombotic events, myocardial infarction and stroke. This risk may swelling with duration of use and in patients with cardiovascular disease or risk factors for cardiovascular disease. Serious gastrointestinal toxicity such as bleeding, ulceration and perforation can take place at any time in patients treat chronically with NSAID psychotherapy and physician should maintain aft alert for such effects even in the fantasy of ancient GI tract symptoms. Patients who are pregnant or are nursing should consult a physician before use of a naproxen-containing medication.



About GlaxoSmithKline GlaxoSmithKline -- one of the world's ascendant research-based pharmaceutical and healthcare guests -- is committed to on the process the faculty of human time by enable people to agree to fly into rule more, bring back the impression greater and in concert longer. For detailed company intelligence, see GlaxoSmithKline's website: About POZEN POZEN is a pharmaceutical company committed to surfacing therapeutic advancement for disease with unmet medical requirements where on earth it can augment efficacy, refuge, and/or forgiving user-friendliness.



Since its inception, POZEN has determined its pains in the main on the fostering of pharmaceutical products for the treatment of acute and ingrained pain, migraine and other pain related provisos. POZEN is also explore the development of product interviewee in other pain-related therapeutic area. POZEN has a development and a commercialization alliance with GlaxoSmithKline. The company's prevailing horses is buying on The Nasdaq Stock Market under the emblem "POZN".



For detailed company information, both with model of this and other constrict untie, see POZEN's website: GlaxoSmithKline




Useful to read about herbal medicine



No comments: